United States· US:22840-1127_36abdd34-8e5a-1315-e063-6294a90a2162

Horse Epithelia

A medicinal product containing equus caballus skin, registered in United States by Greer Laboratories, Inc..

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedHorse EpitheliaATC—REGISTER NO.US:22840-1127_36abdd3…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
EQUUS CABALLUS SKIN
Manufacturer
Greer Laboratories, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    2284011272
    10 mL in 1 VIAL, MULTI-DOSE (22840-1127-2)
  • ndc11
    2284011274
    50 mL in 1 VIAL, MULTI-DOSE (22840-1127-4)
  • ndc11
    22840-1127-2
  • ndc11
    22840-1127-4

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Equus caballus skin in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All equus caballus skin products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Prick-Testlösung Pferdeepithelien, Provokations-Testlösung Pferdeepithelien
  • Hungary · Alyostal Prick Állati Eredetű Allergének

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb1cf2c2-c361-4bda-bae8-84eb91b395fe
GET /v1/drugs/fb1cf2c2-c361-4bda-bae8-84eb91b395fe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS",
  "source": "ndc",
  "strength": "20000",
  "substance": "EQUUS CABALLUS SKIN",
  "productndc": "22840-1127",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "[PNU]/mL",
  "application_number": "BLA101833",
  "marketing_category": "BLA"
}

See everything about equus caballus skin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.